Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

July 27, 2020

Linda Clark and Brad Gallagher Published on Pharmacy Insider Blog

Linda Clark, Health Care Controversies Team leader, and Brad Gallagher, counsel, recently had their “Caremark’s Bold Move to Restrict Dispensing and Access to Products on the Formulary” article published on the Pharmacy Insider blog.

“Suspect product” lists have been used for years by pharmacy benefit managers (PBMs) to target independent pharmacies and subject them to heightened scrutiny. These lists often target high margin products or other drugs that, for other unknown reasons, may be disfavored by PBMs without regard to formularies of individual plans. The lists are secret, and only “word-of-mouth” through the experiences of other network pharmacies do we learn of the targeted products or manufacturers.”

Read the full article here.

Featured Media

Alerts

NYS Energy Planning Board Releases Draft Energy Plan, Detailing Pathways to Decarbonization While Maintaining System Reliability Through 2040

Alerts

Non-Judicial Collateral Remedies, Part 3 – Strict Foreclosure

Alerts

Court to Weigh Key Privacy Issues in Web Tracking Case Against Cigna

Alerts

Attention Providers! OMIG Adopts 12-Month Review Period for Newly Initiated Compliance Program Reviews Beginning July 1, 2025

Alerts

New York Court Upholds NYSDEC's Finding That a Title V Renewal Application Was Consistent With the CLCPA

Alerts

New York Public Service Commission Determines to Withdraw Its Finding in the New York City Offshore Wind Public Policy Transmission Need Process